European Archives - Page 678 of 1392 - European Medical Journal

Asthma Control and Quality of Life Associated With Number of Treatable Traits

The number of treatable traits independent of pharmacological care is associated with asthma control and quality of life…

Is Simultaneous Oral Immunotherapy for Multiple Foods Safe?

Simultaneous oral immunotherapy for multiple foods is feasible and safe via established protocols. Read to find out more…

A Transformational Approach to Managing Allergies to Cats

Prof. Antonella Muraro, University of Padua, Italy and Dr. Ebenezer Satyaraj, Nestle Purina PetCare, St. Louis, MO discuss a novel…

Interview: Edel O’Toole

I was always interested in biology and science. As a child, I loved identifying wild flowers and this is not all that dissimilar to…

An Update on Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis

Patients with osteoporosis should be recognised as being at considerably reduced risk of medication-related osteonecrosis…

Improving Patients’ Adherence to Treatment

This webinar explores patient adherence in dermatology and wider medicine delving into the evidence surrounding why adherence is such a…

Season 4 highlights: GOLD Medal Moments

The GOLD team are delighted to announce that Season 5 of the GOLD Podcast is going to be returning on 6 June!

EMJ

Infographic: MOGAD: A Rare Demyelinating Disease of the CNS

This infographic provides an overview of myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD), covering the peripheral and central pathophysiology pathways, heterogeneous clinical manifestations such as diagnostic criteria, and impact on patients.

Feature image for Microbiology and Infectious Diseases journal. Appears at the top of the page

EMJ Microbiology & Infectious Diseases 4.1 2023

We are delighted to share the latest issue of EMJ Microbiology & Infectious Diseases, featuring a range of peer-reviewed articles…

Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat

Clostridioides difficile (formerly known as Clostridium difficile and commonly referred to as C. difficile) is a Gram-positive anaerobic bacterium that causes CDI.1 It is a leading cause of healthcare-associated infections and is considered a global public health threat.